These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19621977)

  • 1. Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.
    Scahill L
    CNS Drugs; 2009; 23 Suppl 1():43-9. PubMed ID: 19621977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.
    Posey DJ; Puntney JI; Sasher TM; Kem DL; McDougle CJ
    J Child Adolesc Psychopharmacol; 2004; 14(2):233-41. PubMed ID: 15319020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.
    Scahill L; Barloon L; Farkas L
    J Child Adolesc Psychiatr Nurs; 1999; 12(4):168-73. PubMed ID: 10876518
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.
    McCracken JT; Aman MG; McDougle CJ; Tierney E; Shiraga S; Whelan F; Arnold LE; Posey D; Ritz L; Vitiello B; Scahill L
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):1-5. PubMed ID: 20166790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.
    Posey DJ; McDougle CJ
    CNS Drug Rev; 2007; 13(4):465-74. PubMed ID: 18078429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate an effective treatment for ADHD?
    McDougle CJ
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract]   [Full Text] [Related]  

  • 7. In the pipeline: non-stimulant ADHD meds.
    Glazer WM
    Behav Healthc; 2010 Jan; 30(1):30-1. PubMed ID: 20184258
    [No Abstract]   [Full Text] [Related]  

  • 8. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective open trial of guanfacine in children with pervasive developmental disorders.
    Scahill L; Aman MG; McDougle CJ; McCracken JT; Tierney E; Dziura J; Arnold LE; Posey D; Young C; Shah B; Ghuman J; Ritz L; Vitiello B
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Connor DF; Rubin J
    Drugs Today (Barc); 2010 May; 46(5):299-314. PubMed ID: 20517532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
    Mattes JA
    J Am Acad Psychiatry Law; 2016 Jun; 44(2):151-7. PubMed ID: 27236168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR
    Postgrad Med; 2010 Sep; 122(5):78-87. PubMed ID: 20861591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
    Arnsten AF; Scahill L; Findling RL
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):393-406. PubMed ID: 17822336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.
    Hirota T; Schwartz S; Correll CU
    J Am Acad Child Adolesc Psychiatry; 2014 Feb; 53(2):153-73. PubMed ID: 24472251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
    Scahill L; Chappell PB; Kim YS; Schultz RT; Katsovich L; Shepherd E; Arnsten AF; Cohen DJ; Leckman JF
    Am J Psychiatry; 2001 Jul; 158(7):1067-74. PubMed ID: 11431228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of attention-deficit hyperactivity disorder.
    Reeves G; Schweitzer J
    Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autism and attention deficit hyperactivity disorder: pharmacological intervention].
    Fernández-Jaén A; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2013 Sep; 57 Suppl 1():S205-10. PubMed ID: 23897149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological options for the treatment of Tourette's disorder.
    Jiménez-Jiménez FJ; García-Ruiz PJ
    Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.